National evaluation
Th e NIH has contracted with an outside research and evaluation group to conduct a multifaceted external evaluation of the cross-CTSA endeavor from a national perspective. Th is evaluation is summative, rather than formative, and focuses more broadly on changes that the CTSA sites have encouraged and facilitated in the overall clinical and translational research system. For example, the evaluation examines the progress of the CTSA Program in terms of its contribution to strengthening the clinical and translational science workforce via the establishment of CTSA sites, the utilization of CTSA resources by researchers, the implementation of educational and training activities, and the impact of the resources and CTSA activities on institutional and research cultures, on the scientifi c accomplishments of CTSA researchers, and on translational science as a discipline. Some of the methods used for the national evaluation include surveys of researchers and trainees, bibliometric analyses, and site visits to individual institutions.
Cross-CTSA objectives and metrics
Th e individual CTSA sites come together in a networked national consortium that consists of the Executive Committee, the Steering Committee, the Child Health Oversight Committee, 5 Strategic Goal Committees, and 14 Key Function Committees, each of which typically has multiple workgroups with identifi ed projects and activities.
Th e Evaluation Key Function Committee has formed several workgroups focused on diff erent evaluation issues, approaches, and metrics. For example, the Definitions Workgroup has identifi ed key processes or outcomes that need to be operationally defi ned for evaluation purposes, and its eff orts to understand the concept of translational research have resulted in a publication that introduced a process marker and modeling approach. 3 Th e workgroup has also been conducting a cross-site survey of defi nitions and metrics. Th e SNA Workgroup has not only examined SNA as a method of evaluation but has also begun conducting a CTSA pilot project evaluation and a community engagement study, both of which use SNA methodology. Th e Bibliometrics Workgroup has been looking in depth at the methods for bibliometric analysis and has initiated a survey to track all CTSA publications. Th e Shared Resources Workgroup has conducted annual surveys of the 60 evaluation teams to identify common issues and tools that are emerging.
In addition, members of the Evaluation Key Function Committee have partnered with other CTSA committees on matters pertaining to evaluation. For instance, they worked with the Biostatistics, Epidemiology, and Research Design Key Function Committee to develop standard metrics. 4 Th ey helped the Education Key Function Committee identify measures for each factor in the career success model that the committee adopted. community engagement, 6 and they helped the Clinical Research Management Key Function Committee develop and conduct several cross-CTSA studies on the effi ciency of institutional review board processes. Moreover, representatives of the Evaluation Key Function Committee have joined with the national evaluation external contractor, the NCRR, and other NIH representatives to form the National Evaluation Liaison Group, whose objective is to encourage coordination and greater effi ciency of local and national eff orts at CTSA evaluation.
The Future of CTSA Evaluation
Th e NIH has now reached its target of funding 60 CTSA sites, some of which are in their sixth year of research. Because the CTSA Program is expected to become a major component of the NIH's proposed National Center for Advancing Translational Science (NCATS), the upcoming evaluations of CTSA sites will be crucial in plotting the future of clinical and translational science research.
Th e National Evaluation Liaison Group has worked with the American Evaluation Association to draft a white paper that provides an evaluation policy framework for the CTSA sites. In addition, it has worked with the national evaluation external contractor and the NCRR to draft a logic model that creates a shared vision for the CTSA sites during the next 5 years. Th is model addresses what the group considers to be the most critical research questions related to clinical and translational science and lays the groundwork for an integrated, comprehensive evaluation of efforts to meet CTSA goals. Although the Evaluation Key Function Committee recognizes that the logic model and its associated research questions can continue to be refi ned, its members have unanimously agreed that the model is consistent with the direction the evaluation should take over the next 5 years.
Conclusion
Th e complex, multilevel, networked consortium of 60 CTSA sites required an evaluation eff ort that could assess the varied and multifaceted activities of the individual sites and the consortium as a whole. Th e evaluation "ecology" that evolved over the fi rst 5 years of the CTSA initiative is well positioned to address the continued requirements of the initiative and to serve as a model for other largescale multicenter research initiatives at the NIH and elsewhere.
